Centessa Pharmaceuticals plc
NASDAQ:CNTA
17.16 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Assets: | ||||
| Current Assets: | ||||
| Cash & Cash Equivalents
| 128.03 | 393.644 | 595.082 | 7.227 |
| Short Term Investments
| 128.519 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 256.549 | 393.644 | 595.082 | 7.227 |
| Net Receivables
| 39.148 | 26.723 | 16.814 | 0 |
| Inventory
| 0 | -29.994 | -17.807 | 1.001 |
| Other Current Assets
| 19.395 | 17.38 | 16.878 | 3.938 |
| Total Current Assets
| 315.092 | 393.644 | 595.082 | 11.165 |
| Non-Current Assets: | ||||
| Property, Plant & Equipment, Net
| 12.953 | 1.168 | 0.162 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 |
| Tax Assets
| 29.647 | 3.512 | 0 | 0 |
| Other Non-Current Assets
| 2.554 | 45.983 | 34.391 | 0.552 |
| Total Non-Current Assets
| 45.154 | 50.663 | 34.553 | 0.552 |
| Total Assets
| 360.246 | 444.307 | 629.635 | 11.717 |
| Liabilities & Equity: | ||||
| Current Liabilities: | ||||
| Account Payables
| 11.815 | 13.836 | 7.296 | 1.032 |
| Short Term Debt
| 0 | 0 | 0 | 5.627 |
| Tax Payables
| 0.112 | 1.582 | 0.769 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 1.038 |
| Other Current Liabilities
| 27.458 | 22.92 | 16.573 | 1.96 |
| Total Current Liabilities
| 39.385 | 38.338 | 24.638 | 8.619 |
| Non-Current Liabilities: | ||||
| Long Term Debt
| 84.588 | 69.8 | 75.7 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.029 | 0 | 37.743 | 0 |
| Total Non-Current Liabilities
| 84.617 | 108.138 | 138.081 | 25.521 |
| Total Liabilities
| 124.002 | 108.138 | 138.081 | 34.14 |
| Equity: | ||||
| Preferred Stock
| 0 | 0 | 0 | 0.044 |
| Common Stock
| 0.273 | 0.265 | 0.252 | 0.021 |
| Retained Earnings
| -752.945 | -601.86 | -385.653 | -22.423 |
| Accumulated Other Comprehensive Income/Loss
| 1.493 | -1.497 | 0.688 | -0.086 |
| Other Total Stockholders Equity
| 987.423 | 939.261 | 876.267 | 20.652 |
| Total Shareholders Equity
| 236.244 | 336.169 | 491.554 | -22.423 |
| Total Equity
| 236.244 | 336.169 | 491.554 | -22.423 |
| Total Liabilities & Shareholders Equity
| 360.246 | 444.307 | 629.635 | 11.717 |